ACTIVIN RECEPTOR-LIKE KINASE AND THE INSULIN GENE

被引：8

作者：

Watanabe, Rie ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto 606, Japan

来源：

ACTIVINS AND INHIBINS | 2011年 / 85卷

关键词：

TRANSFORMING-GROWTH-FACTOR; SERINE-THREONINE KINASE; PANCREATIC BETA-CELLS; EMBRYONIC STEM-CELLS; BONE MORPHOGENETIC PROTEIN; TRANSCRIPTION CONTROL REGION; HUMAN ENDOTHELIAL-CELLS; TGF-BETA; II RECEPTOR; SERINE/THREONINE KINASE;

D O I：

10.1016/B978-0-12-385961-7.00001-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The biological responses of the transforming growth factor-beta (TGF-beta) superfamily, which includes Activins and Nodal, are induced by activation of a receptor complex and Smads. A type I receptor, which is a component of the complex, is known as an activin receptor-like kinase (ALK); currently seven ALKs (ALK1-ALK7) have been identified in humans. Activins signaling, which is mediated by ALK4 and 7 together with ActRIIA and IIB, plays a critical role in glucose-stimulated insulin secretion, development/neogenesis, and glucose homeostatic control of pancreatic endocrine cells; the insulin gene is regulated by these signaling pathways via ALK7, which is a receptor for Activins AB and B and Nodal. This review discusses signal transduction of ALKs in pancreatic endocrine cells and the role of ALKs in insulin gene regulation. (C) 2011 Elsevier Inc.

引用

页码：1 / 27

页数：27

共 50 条

[21] Targeting heterotopic ossification by inhibiting activin receptor-like kinase 2 function
Shi, Fuli
Gao, Jiayu
Zou, Junrong
Ying, Ying
Lin, Hui
MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 2979 - 2989
[22] The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2
Berg, JN
Gallione, CJ
Stenzel, TT
Johnson, DW
Allen, WP
Schwartz, CE
Jackson, CE
Porteous, MEM
Marchuk, DA
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) : 60 - 67
[23] Activin receptor-like kinase 7 promotes insulin gene transcription through insulin promoter factor 1 (IPF1) via Smad3
Watanabe, R
Yamada, Y
Ihara, Y
Shen, ZP
Seino, Y
DIABETES, 2000, 49 : A258 - A258
[24] Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7
Vestal, Kylie A.
Kattamuri, Chandramohan
Koyiloth, Muhasin
Ongaro, Luisina
Howard, James A.
Deaton, Aimee M.
Ticau, Simina
Dubey, Aditi
Bernard, Daniel J.
Thompson, Thomas B.
BIOCHEMICAL JOURNAL, 2024, 481 (07) : 547 - 564
[25] Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors
Mansour, Mai A.
Hassan, Ghaneya S.
Serya, Rabah A. T.
Jaballah, Maiy Y.
Abouzid, Khaled A. M.
BIOORGANIC CHEMISTRY, 2024, 147
[26] The Expression of Activin Receptor-Like Kinase 1 among Patients with Head and Neck Cancer
Chien, Chih-Yen
Chuang, Hui-Ching
Chen, Chang-Han
Fang, Fu-Min
Chen, Wei-Chih
Huang, Chao-Cheng
Huang, Hsuan-Ying
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2013, 148 (06) : 965 - 973
[27] Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues
Ruan, Xianchun
Zhang, Zhaowei
Aili, Munire
Luo, Xiang
Wei, Qiang
Zhang, Demao
Bai, Mingru
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
[28] Uterine activin receptor-like kinase 5 is crucial for blastocyst implantation and placental development
Peng, Jia
Monsivais, Diana
You, Ran
Zhong, Hua
Pangas, Stephanie A.
Matzuk, Martin M.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (36) : E5098 - E5107
[29] Targeting activin receptor-like kinase 7 ameliorates adiposity and associated metabolic disorders
Zhao, Min
Okunishi, Katsuhide
Bu, Yun
Kikuchi, Osamu
Wang, Hao
Kitamura, Tadahiro
Izumi, Tetsuro
JCI INSIGHT, 2023, 8 (04)
[30] Dihydromyricetin attenuates hypertrophic scar formation by targeting activin receptor-like kinase 5
Ye, Xiaolu
Pang, Zhiying
Zhu, Ningwen
EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 852 : 58 - 67

← 1 2 3 4 5 →